LifeMine Therapeutics
Cambridge, US · Founded 2016 · Delaware corporation · 3 known investors
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
Founders & leadership
GL
Gregory L. VerdineExecutive Officer, Director
HH
Hingge HsuExecutive Officer, Director
WZ
Weiqing ZhouExecutive Officer, Director
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$70.1MraisedMar 2019 · 10 investors · BiotechnologyRule 506(b)
▶$70.1MraisedMar 2019 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- WeiQing ZhouExecutive Officer
- Gregory L. VerdineExecutive Officer, Director
- Yanling CaoDirector
- Richard KlausnerDirector
- Wei LiDirector
- Krishna YeshwantDirector
- Offering amount
- $70.1M
- Amount sold
- $70.1M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$5MraisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gregory L. VerdineExecutive Officer, Director
- Hingge HsuExecutive Officer, Director
- Weiqing ZhouExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- LifeMine Announces First Participant Dosed in First-in-human Phase 1 Clinical Trial of LIFE-001, Designed De Novo to Become a Field Dominating Immunosuppressive for Immune-mediated Disorders and Transplantationbusinesswire.com · 2025
- GSK-Backed LifeMine Nets $175M and More Financing News - BioSpacebiospace.com · 2022
- LifeMine locks down $70M 'dream scenario' fungi partnership with GSK—and a fundraising, too | Fierce Biotechfiercebiotech.com · 2022
- LifeMine Therapeutics Announces $175 Million Series C Financingbusinesswire.com · 2022
- LifeMine Therapeutics raises USD175m in Series C round led by Fidelity Management & Research Company - Private Equity Wireprivateequitywire.co.uk · 2022
- LifeMine raises $175m to find drugs from fungi - The Boston Globebostonglobe.com · 2022